Anika Therapeutics, Inc.

ANIK · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$55,629$68,740$86,327$94,386
Short-Term Investments$0$0$0$0
Receivables$23,594$26,360$34,627$29,843
Inventory$23,809$24,428$39,765$36,010
Other Curr. Assets$10,620$43,781$8,828$8,289
Total Curr. Assets$113,652$163,309$169,547$168,528
Property Plant & Equip (Net)$64,679$64,999$78,975$68,559
Goodwill$7,125$7,571$7,339$7,781
Intangibles$2,490$2,576$74,599$82,382
Long-Term Investments$0$0$0$0
Tax Assets$1,177$1,489$1,449$0
Other NC Assets$13,617$30,688$17,219$20,285
Total NC Assets$89,088$107,323$179,581$179,007
Other Assets$0$0$0$0
Total Assets$202,740$270,632$349,128$347,535
Liabilities
Payables$5,617$6,194$9,074$7,633
Short-Term Debt$1,918$1,827$2,073$1,714
Tax Payable$63$1,240$810$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$15,708$21,798$15,957$20,448
Total Curr. Liab.$23,306$31,059$27,914$29,795
LT Debt$24,014$25,915$28,817$19,240
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$6,436$10,157
Other NC Liab.$1,431$1,393$398$1,258
Total NC Liab.$25,445$27,308$35,651$30,655
Other Liabilities$0$0$0$0
Cap. Leases$25,932$27,742$30,890$20,954
Total Liabilities$48,751$58,367$63,565$60,450
Equity
Pref Stock$0$0$0$0
Common Stock$144$147$146$144
Retained Earnings$71,667$128,052$210,719$225,578
AOCI-$6,783-$5,943-$6,443-$5,718
Other Equity$88,961$90,009$81,141$67,081
Total Equity$153,989$212,265$285,563$287,085
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$202,740$270,632$349,128$347,535
Net Debt-$29,697-$40,998-$55,437-$73,432